85 results
Page 3 of 5
6-K
EX-99.2
7jj8no
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
igggrf7dh 600hv25ih
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
vhag k34w
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
vqw25y9rer1j5l
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
gp7h3r4n1ksbr
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.2
2vi2dhj 0p
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
iyf rzrbi63
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
gadr8t
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
kq5g9b
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.2
w8c6gec
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
3iq7fy0
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.2
agy6i d94ee7
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
gb6sawmyalkg7tas3uh
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.2
bpq4jwn
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
bx15 g00ziqo0zlus2zd
29 Jan 20
Current report (foreign)
6:05am
6-K
EX-99.2
tlv1fta71tvn
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.9
uxmeti 3phdk2q
20 Sep 19
Current report (foreign)
4:07pm
6-K
EX-99.1
t5ks4rh q2itjzz2b
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm